Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Tobacco Use Disorder 4Uterine Cervical Neoplasms 3Neoplasms 3Breast Neoplasms 3Tobacco Use Cessation 2Smoking Cessation 2Smoking 2Lung Neoplasms 2Head and Neck Neoplasms 2Cigarette Smoking 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Tobacco Use 1Tobacco Smoking 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Health Education 1Hand-Foot Syndrome 1

Interventions

Tobacco Use Cessation Devices 1Radiotherapy 1Celecoxib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hand-Foot Syndrome × Tobacco Use Cessation Devices × Clear all
NCT00751101 2020-10-05

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

University of California, San Francisco

Phase 2 Terminated
24 enrolled 12 charts
Breast

Breast Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡